Microarray versus conventional prediction of lymph node metastasis in colorectal carcinoma.

  title={Microarray versus conventional prediction of lymph node metastasis in colorectal carcinoma.},
  author={Roland Croner and Andrea Peters and Wolfgang Michael Brueckl and Klaus E. Matzel and Ludger Klein-Hitpass and T. Brabletz and Thomas Papadopoulos and Werner Hohenberger and Bertram Reingruber and Berthold Lausen},
  volume={104 2},
BACKGROUND The authors investigated whether microarray-based gene expression analysis of primary tumor biopsy material could be used to predict lymph node status in patients with colorectal carcinoma (CRC). Lymphatic metastasis strongly determines treatment algorithms in CRC. Currently, postoperative histology results are needed to determine lymph node status. Reliable preoperative information would be useful to advance treatment strategies. METHODS In specimens from 66 patients with CRC from… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 26 extracted citations

Guidelines for biomarker testing in colorectal carcinoma (CRC): a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM).

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico • 2012
View 1 Excerpt

Similar Papers

Loading similar papers…